Fortress Biotech Reports on Shareholder Vote

Ticker: FBIOP · Form: 8-K · Filed: Jun 23, 2025 · CIK: 1429260

Fortress Biotech, INC. 8-K Filing Summary
FieldDetail
CompanyFortress Biotech, INC. (FBIOP)
Form Type8-K
Filed DateJun 23, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: shareholder-vote, corporate-governance

Related Tickers: FBIO

TL;DR

FBIO held a shareholder vote on June 17th, details filed today.

AI Summary

Fortress Biotech, Inc. filed an 8-K on June 23, 2025, reporting on matters submitted to a vote of security holders on June 17, 2025. The filing pertains to their common stock and Series Cumulative Redeemable Perpetual Preferred Stock.

Why It Matters

This filing indicates that Fortress Biotech held a shareholder meeting to vote on important corporate matters, which could impact the company's future direction and shareholder rights.

Risk Assessment

Risk Level: low — The filing is a routine 8-K reporting on a shareholder vote, not indicating any immediate financial distress or significant new risks.

Key Players & Entities

FAQ

What specific matters were submitted to a vote of Fortress Biotech's security holders on June 17, 2025?

The filing states that matters were submitted to a vote of security holders on June 17, 2025, but does not detail the specific proposals in this section of the 8-K.

What type of stock is mentioned in relation to the June 17, 2025 event?

The filing mentions both 'CommonStockMember' and 'SeriesCumulativeRedeemablePerpetualPreferredStockMember' in relation to the date June 17, 2025.

When was this 8-K form filed with the SEC?

This 8-K form was filed as of June 23, 2025.

What is Fortress Biotech's principal executive office address?

Fortress Biotech, Inc.'s principal executive office is located at 1111 Kane Concourse, Suite 301, Bay Harbor Islands, FL 33154.

What is Fortress Biotech's IRS Employer Identification Number?

Fortress Biotech, Inc.'s IRS Employer Identification Number is 20-5157386.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 23, 2025 regarding Fortress Biotech, Inc. (FBIOP).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing